Acquisition of Q-band Pulsed EPR Capability

获得Q波段脉冲EPR能力

基本信息

  • 批准号:
    8245467
  • 负责人:
  • 金额:
    $ 38.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-01 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application is for an upgrade to Q-band for our current Bruker X-band E580 pulse spectrometer capable of running DEER (double electron-electron resonance), DQC (double quantum coherence), and ENDOR (electron nuclear double resonance) experiments at cryogenic temperatures. The primary use of both the current and upgraded instrument will be to quantitate distance measurements between paramagnetic probes on or within biomedically relevant proteins. The major advantages of upgrading to Q-band (35 GHz) DEER from X-band (9 GHz) DEER are a >10-fold increase in sensitivity and overall higher quality distance data. The improvement in resolution, accuracy, identification, signal intensity and the collection of longer distances will be of considerable benefit to an array of biological projects. Additional advantages of pulsed Q- band over X-band include smaller sample volumes, lower overall sample concentration requirements, and significantly decreased data collection times. Pulsed Q-band ENDOR also provides technological and fundamental benefits over X-band ENDOR. The Q-band resonator allows for significantly higher radio frequency (RF) fields for a given supplied power, which is often the limiting factor in ENDOR sensitivity, and the microwave field is increased at Q-band; these allow for the study of fast-relaxing systems that are not amenable to pulsed X-band or continuous-wave ENDOR. In addition, 14N and 1H ENDOR resonances typically overlap at X-band, yet are readily assigned at Q-band. Each one of these is a remarkable advantage to biological research projects and coupled with the considerable improvement in data accuracy will have a substantial impact on current and future structural biology studies of soluble and membrane proteins and protein complexes. Frequencies higher than Q-band provide little additional benefit to the proposed experiments, thus this upgrade request is for the optimum instrument for long-term pulse EPR spectroscopy use. This type of state-of-the-art Q-band pulsed EPR instrumentation is lacking not only at the Medical College of Wisconsin but in entire the state of Wisconsin. Five major users are identified who will measure long-range distances within proteins and protein complexes. In addition, numerous minor users are identified, each with a need for advanced pulse instrumentation not available in the region. Specifically, the research benefiting from the requested upgrade will contribute to a better understanding of the physiology of disease processes such as epilepsy, arrhythmia, neurological disorders, and cancer, and to the development of novel antibiotics and cancer therapeutic agents. Additional opportunities are expected to be uncovered once the success of the initially proposed projects is evident, opening up further avenues of interdisciplinary science. This upgraded instrumentation capability will immediately and significantly advance the productivity of the projects outlined in this proposal as well as enhance the research environment for the surrounding community.
描述(由申请人提供):本申请旨在将我们目前的布鲁克X波段E580脉冲光谱仪升级到Q波段,该光谱仪能够在低温下运行DEER(双电子-电子共振)、DQC(双量子相干)和ENDOR(电子核双共振)实验。当前仪器和升级仪器的主要用途是定量生物医学相关蛋白质上或内的顺磁探针之间的距离测量。从X波段(9 GHz)DEER升级到Q波段(35 GHz)DEER的主要优点是灵敏度提高了10倍以上,距离数据的质量总体上更高。分辨率、准确性、识别、信号强度和更长距离收集的改进将对一系列生物项目产生相当大的好处。脉冲Q波段相对于X波段的其他优点包括更小的样品体积、更低的总体样品浓度要求以及显著减少的数据收集时间。脉冲Q波段ENDOR还提供了超过X波段ENDOR的技术和基本优势。Q波段谐振器允许对于给定的供应功率显著更高的射频(RF)场,这通常是ENDOR灵敏度的限制因素,并且微波场在Q波段增加;这些允许研究不适合脉冲X波段或连续波ENDOR的快速弛豫系统。此外,14 N和1H ENDOR共振通常在X波段重叠,但很容易在Q波段分配。其中每一个都是生物学研究项目的显着优势,加上数据准确性的显著提高,将对当前和未来的可溶性和膜蛋白和蛋白质复合物的结构生物学研究产生重大影响。高于Q波段的频率对所提出的实验几乎没有额外的好处,因此这种升级要求是为了长期使用脉冲EPR光谱的最佳仪器。这种类型的国家的最先进的Q波段脉冲EPR仪器是缺乏不仅在威斯康星州的医学院,但在整个威斯康星州的状态。确定了五个主要用户,他们将测量蛋白质和蛋白质复合物内的长距离。此外,还确定了许多小用户,每个用户都需要该区域没有的先进脉冲仪器。具体来说,受益于所要求的升级的研究将有助于更好地了解癫痫、心律失常、神经系统疾病和癌症等疾病过程的生理学,并有助于新型抗生素和癌症治疗剂的开发。一旦初步提出的项目取得明显成功,预计将发现更多的机会,从而开辟跨学科科学的进一步途径。这种升级的仪器能力将立即显着提高本提案中概述的项目的生产力,并改善周围社区的研究环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CANDICE S KLUG其他文献

CANDICE S KLUG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CANDICE S KLUG', 18)}}的其他基金

Development of high-throughput, high-sensitivity EPR sample handling capabilities for biomedical research
开发用于生物医学研究的高通量、高灵敏度 EPR 样品处理能力
  • 批准号:
    10530690
  • 财政年份:
    2021
  • 资助金额:
    $ 38.09万
  • 项目类别:
Administrative Supplement to Development of high-throughput, high-sensitivity EPR sample handling capabilities for biomedical research
生物医学研究高通量、高灵敏度 EPR 样品处理能力开发的行政补充
  • 批准号:
    10796325
  • 财政年份:
    2021
  • 资助金额:
    $ 38.09万
  • 项目类别:
Development of high-throughput, high-sensitivity EPR sample handling capabilities for biomedical research
开发用于生物医学研究的高通量、高灵敏度 EPR 样品处理能力
  • 批准号:
    10323039
  • 财政年份:
    2021
  • 资助金额:
    $ 38.09万
  • 项目类别:
Lpt protein-mediated transport of LPS
Lpt 蛋白介导的 LPS 转运
  • 批准号:
    10016341
  • 财政年份:
    2014
  • 资助金额:
    $ 38.09万
  • 项目类别:
LptA-mediated transport of LPS
LptA 介导的 LPS 转运
  • 批准号:
    9068198
  • 财政年份:
    2014
  • 资助金额:
    $ 38.09万
  • 项目类别:
LptA-mediated transport of LPS
LptA 介导的 LPS 转运
  • 批准号:
    8919418
  • 财政年份:
    2014
  • 资助金额:
    $ 38.09万
  • 项目类别:
Lpt protein-mediated transport of LPS
Lpt 蛋白介导的 LPS 转运
  • 批准号:
    10205081
  • 财政年份:
    2014
  • 资助金额:
    $ 38.09万
  • 项目类别:
Lpt protein-mediated transport of LPS
Lpt 蛋白介导的 LPS 转运
  • 批准号:
    9816218
  • 财政年份:
    2014
  • 资助金额:
    $ 38.09万
  • 项目类别:
LptA-mediated transport of LPS
LptA 介导的 LPS 转运
  • 批准号:
    9275484
  • 财政年份:
    2014
  • 资助金额:
    $ 38.09万
  • 项目类别:
LptA-mediated transport of LPS
LptA 介导的 LPS 转运
  • 批准号:
    8756571
  • 财政年份:
    2014
  • 资助金额:
    $ 38.09万
  • 项目类别:

相似海外基金

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
  • 批准号:
    495592
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
  • 批准号:
    23K14885
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
  • 批准号:
    10668025
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
  • 批准号:
    23K09597
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
  • 批准号:
    514892030
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
    WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
  • 批准号:
    10722857
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 38.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了